Molecular Templates, Inc. - FORM 8-K - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP

Attached files

file	filename
8-K - FORM 8-K - Molecular Templates, Inc.	d8k.htm
EX-4.1 - FORM OF WARRANT TO PURCHASE COMMON STOCK - Molecular Templates, Inc.	dex41.htm
EX-4.2 - THIRD AMENDMENT TO RIGHTS AGREEMENT - Molecular Templates, Inc.	dex42.htm
EX-1.1 - UNDERWRITING AGREEMENT - Molecular Templates, Inc.	dex11.htm
EX-5.1 - OPINION OF MORRISON & FOERSTER LLP - Molecular Templates, Inc.	dex51.htm
EX-99.1 - PRESS RELEASE - Molecular Templates, Inc.	dex991.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (Registration No. 333-169689) of our report dated March 8, 2010, except with respect to the disclosures under the heading “Liquidity” in Note 1, as to which the date is March 11, 2011, relating to the consolidated financial statements which appear in Threshold Pharmaceuticals, Inc.’s prospectus supplement dated March 11, 2011. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

San Jose, CA

March 11, 2011

Attached files

Stock widget

Investing forum

Molecular Templates, Inc. Reports